Description:
Candida albicans is one of the fungal species most commonly causing life threatening infections in vulnerable patients. Our group is studying the mitochondria in Candida albicans cells.
Just like in our cells the mitochondria are the batteries of the cell, producing energy required for growth and in fungal cells can also influence infection.
The mitochondria can influence components of the fungal cell wall and its ability to infect us.
If we understand how mitochondria are influencing these factors, we can develop new anti-fungals or we can use existing anti-fungals in new combinations in order to tackle life threatening infections.
Lucian Duvenage works in Dr Campbell Gourlay’s lab at the University of Kent
Medical and Patient education videos
-
Title
Description
-
Talk by Gilbert Massard – at the Aspergillosis for Patients meeting in Rome, Feb 3rd 2010
-
Talk by David Andes – at the Aspergillosis for Patients meeting in Rome, Feb 3rd 2010.
-
Talk by Brahm Segal – at the Aspergillosis for Patients meeting in Rome, Feb 3rd, 2010.
-
Talk by David Denning – at the Aspergillosis for Patients meeting in Rome, Feb 3rd, 2010.
-
Talk by Russell Lewis – at the Aspergillosis for Patients meeting in Rome, Feb 3rd, 2010.
-
An introduction to this meeting by Dr Geoffrey Scott, Consultant Microbiologist.
-
Talk by Rick Moss – at the Aspergillosis for Patients meeting in Rome, Feb 3rd, 2010.
-
Talk by Malcolm Richardson – at the Aspergillosis for Patients meeting in Rome, Feb 3rd, 2010, with specific references to aspergillus.
-
Opening of the UK’s first National Centre for Aspergillosis was marked by a series of short talks from Doctors, Scientists and Patients.
